- GlobeNewswire•23 days ago
CRANBURY, N.J., April 06, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, is supporting several activities during Fabry Disease Awareness Month ...
- GlobeNewswire•26 days ago
Target Exceeded with More than 160 Patients Enrolled. Top-Line Data on Track for 3 Q17. CRANBURY, N.J., April 03, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies ...
- Accesswire•last month
NEW YORK, NY / ACCESSWIRE / March 17, 2017 / There has been significant interest in both companies by investment rating firms and individual investors over the past quarter. The interest is not necessarily ...
FOLD: Summary for Amicus Therapeutics, Inc. - Yahoo Finance
Amicus Therapeutics, Inc. (FOLD)
NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
|Bid||6.01 x 100|
|Ask||8.25 x 100|
|Day's range||7.58 - 7.89|
|52-week range||4.41 - 9.61|
Trade prices are not sourced from all markets
|PE ratio (TTM)||-5.16|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|